Application 211988
- Type
- NDA
- Sponsor
- Heron Therapeutics, Inc.
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | Zynrelef | bupivacaine and meloxicam | SOLUTION;INJECTION | 60MG/1.8MG | No | No |
| 002 | Zynrelef | bupivacaine and meloxicam | SOLUTION; INJECTION | 200MG/6MG | No | No |
| 003 | Zynrelef | bupivacaine and meloxicam | SOLUTION; INJECTION | 300MG/9MG | No | No |
| 004 | Zynrelef | bupivacaine and meloxicam | SOLUTION; INJECTION | 400MG/12MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N211988-001 | ZYNRELEF KIT | BUPIVACAINE; MELOXICAM | 60MG/2.3ML (29.25MG/ML);1.8MG/2.3ML (0.88MG/ML) | SOLUTION, EXTENDED RELEASE / PERIARTICULAR | RLD | 2021-05-12 | |
| N211988-002 | ZYNRELEF KIT | BUPIVACAINE; MELOXICAM | 200MG/7ML (29.25MG/ML);6MG/7ML (0.88MG/ML) | SOLUTION, EXTENDED RELEASE / PERIARTICULAR | RLD, RS | 2021-05-12 | |
| N211988-003 | ZYNRELEF KIT | BUPIVACAINE; MELOXICAM | 300MG/10.5ML (29.25MG/ML);9MG/10.5ML (0.88MG/ML) | SOLUTION, EXTENDED RELEASE / PERIARTICULAR | RLD | 2021-05-12 | |
| N211988-004 | ZYNRELEF KIT | BUPIVACAINE; MELOXICAM | 400MG/14ML (29.25MG/ML);12MG/14ML (0.88MG/ML) | SOLUTION, EXTENDED RELEASE / PERIARTICULAR | RLD, RS | 2021-05-12 |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N211988-001 | 10398686 | 2034-03-13 | Drug product | 2021-05-26 | |
| N211988-001 | 11253504 | 2034-03-13 | U-3118 | 2022-03-02 | |
| N211988-001 | 9592227 | 2034-03-13 | U-3118 | Drug product | 2021-05-26 |
| N211988-001 | 9744163 | 2034-03-13 | Drug product | 2021-05-26 | |
| N211988-001 | 9913909 | 2034-03-13 | U-3118 | 2021-05-26 | |
| N211988-001 | 10098957 | 2035-04-20 | U-3118 | 2021-05-26 | |
| N211988-001 | 10213510 | 2035-04-20 | U-3118 | Drug product | 2021-05-26 |
| N211988-001 | 10632199 | 2035-04-20 | U-3118 | Drug product | 2021-05-26 |
| N211988-001 | 10898575 | 2035-04-20 | U-3118 | Drug product | 2021-05-26 |
| N211988-001 | 10980886 | 2035-04-20 | Drug product | 2021-05-26 | |
| N211988-001 | 11083730 | 2035-04-20 | U-3118 | Drug product | 2021-08-25 |
| N211988-001 | 11083797 | 2035-04-20 | U-3118 | Drug product | 2021-08-25 |
| N211988-001 | 11413350 | 2035-04-20 | U-3417 | 2022-09-15 | |
| N211988-001 | 9694079 | 2035-04-20 | U-3118 | Drug product | 2021-05-26 |
| N211988-001 | 9801945 | 2035-04-20 | U-3118 | Drug product | 2021-05-26 |
| N211988-001 | 11844837 | 2036-04-21 | U-3417 | 2024-01-03 | |
| N211988-002 | 10398686 | 2034-03-13 | Drug product | 2021-05-26 | |
| N211988-002 | 11253504 | 2034-03-13 | U-3118 | 2022-03-02 | |
| N211988-002 | 9592227 | 2034-03-13 | U-3118 | Drug product | 2021-05-26 |
| N211988-002 | 9744163 | 2034-03-13 | Drug product | 2021-05-26 | |
| N211988-002 | 9913909 | 2034-03-13 | U-3118 | 2021-05-26 | |
| N211988-002 | 10098957 | 2035-04-20 | U-3118 | 2021-05-26 | |
| N211988-002 | 10213510 | 2035-04-20 | U-3118 | Drug product | 2021-05-26 |
| N211988-002 | 10632199 | 2035-04-20 | U-3118 | Drug product | 2021-05-26 |
| N211988-002 | 10898575 | 2035-04-20 | U-3118 | Drug product | 2021-05-26 |
| N211988-002 | 10980886 | 2035-04-20 | Drug product | 2021-05-26 | |
| N211988-002 | 11083730 | 2035-04-20 | U-3118 | Drug product | 2021-08-25 |
| N211988-002 | 11083797 | 2035-04-20 | U-3118 | Drug product | 2021-08-25 |
| N211988-002 | 11413350 | 2035-04-20 | U-3417 | 2022-09-15 | |
| N211988-002 | 9694079 | 2035-04-20 | U-3118 | Drug product | 2021-05-26 |
| N211988-002 | 9801945 | 2035-04-20 | U-3118 | Drug product | 2021-05-26 |
| N211988-002 | 11844837 | 2036-04-21 | U-3417 | 2024-01-03 | |
| N211988-003 | 10398686 | 2034-03-13 | Drug product | 2021-05-26 | |
| N211988-003 | 11253504 | 2034-03-13 | U-3118 | 2022-03-02 | |
| N211988-003 | 9592227 | 2034-03-13 | U-3118 | Drug product | 2021-05-26 |
| N211988-003 | 9744163 | 2034-03-13 | Drug product | 2021-05-26 | |
| N211988-003 | 9913909 | 2034-03-13 | U-3118 | 2021-05-26 | |
| N211988-003 | 10098957 | 2035-04-20 | U-3118 | 2021-05-26 | |
| N211988-003 | 10213510 | 2035-04-20 | U-3118 | Drug product | 2021-05-26 |
| N211988-003 | 10632199 | 2035-04-20 | U-3118 | Drug product | 2021-05-26 |
| N211988-003 | 10898575 | 2035-04-20 | U-3118 | Drug product | 2021-05-26 |
| N211988-003 | 10980886 | 2035-04-20 | Drug product | 2021-05-26 | |
| N211988-003 | 11083730 | 2035-04-20 | U-3118 | Drug product | 2021-08-25 |
| N211988-003 | 11083797 | 2035-04-20 | U-3118 | Drug product | 2021-08-25 |
| N211988-003 | 11413350 | 2035-04-20 | U-3417 | 2022-09-15 | |
| N211988-003 | 9694079 | 2035-04-20 | U-3118 | Drug product | 2021-05-26 |
| N211988-003 | 9801945 | 2035-04-20 | U-3118 | Drug product | 2021-05-26 |
| N211988-003 | 11844837 | 2036-04-21 | U-3417 | 2024-01-03 | |
| N211988-004 | 10398686 | 2034-03-13 | Drug product | 2021-05-26 | |
| N211988-004 | 11253504 | 2034-03-13 | U-3118 | 2022-03-02 | |
| N211988-004 | 9592227 | 2034-03-13 | U-3118 | Drug product | 2021-05-26 |
| N211988-004 | 9744163 | 2034-03-13 | Drug product | 2021-05-26 | |
| N211988-004 | 9913909 | 2034-03-13 | U-3118 | 2021-05-26 | |
| N211988-004 | 10098957 | 2035-04-20 | U-3118 | 2021-05-26 | |
| N211988-004 | 10213510 | 2035-04-20 | U-3118 | Drug product | 2021-05-26 |
| N211988-004 | 10632199 | 2035-04-20 | U-3118 | Drug product | 2021-05-26 |
| N211988-004 | 10898575 | 2035-04-20 | U-3118 | Drug product | 2021-05-26 |
| N211988-004 | 10980886 | 2035-04-20 | Drug product | 2021-05-26 | |
| N211988-004 | 11083730 | 2035-04-20 | U-3118 | Drug product | 2021-08-25 |
| N211988-004 | 11083797 | 2035-04-20 | U-3118 | Drug product | 2021-08-25 |
| N211988-004 | 11413350 | 2035-04-20 | U-3417 | 2022-09-15 | |
| N211988-004 | 9694079 | 2035-04-20 | U-3118 | Drug product | 2021-05-26 |
| N211988-004 | 9801945 | 2035-04-20 | U-3118 | Drug product | 2021-05-26 |
| N211988-004 | 11844837 | 2036-04-21 | U-3417 | 2024-01-03 |
Orange Book exclusivity#
| Application-product | Exclusivity code | Expiration |
|---|---|---|
| N211988-001 | I-933 | 2027-01-23 |
| N211988-002 | I-933 | 2027-01-23 |
| N211988-003 | I-933 | 2027-01-23 |
| N211988-004 | I-933 | 2027-01-23 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | N211988-001 | ZYNRELEF KIT | 60MG/2.3ML (29.25MG/ML);1.8MG/2.3ML (0.88MG/ML) | SOLUTION, EXTENDED RELEASE / PERIARTICULAR | RLD | 2021-05-12 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N211988-002 | ZYNRELEF KIT | 200MG/7ML (29.25MG/ML);6MG/7ML (0.88MG/ML) | SOLUTION, EXTENDED RELEASE / PERIARTICULAR | RLD, RS | 2021-05-12 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N211988-003 | ZYNRELEF KIT | 300MG/10.5ML (29.25MG/ML);9MG/10.5ML (0.88MG/ML) | SOLUTION, EXTENDED RELEASE / PERIARTICULAR | RLD | 2021-05-12 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N211988-004 | ZYNRELEF KIT | 400MG/14ML (29.25MG/ML);12MG/14ML (0.88MG/ML) | SOLUTION, EXTENDED RELEASE / PERIARTICULAR | RLD, RS | 2021-05-12 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N211988-001 | ZYNRELEF KIT | 60MG/2.3ML (29.25MG/ML);1.8MG/2.3ML (0.88MG/ML) | SOLUTION, EXTENDED RELEASE / PERIARTICULAR | RLD | 2021-05-12 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N211988-002 | ZYNRELEF KIT | 200MG/7ML (29.25MG/ML);6MG/7ML (0.88MG/ML) | SOLUTION, EXTENDED RELEASE / PERIARTICULAR | RLD, RS | 2021-05-12 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N211988-003 | ZYNRELEF KIT | 300MG/10.5ML (29.25MG/ML);9MG/10.5ML (0.88MG/ML) | SOLUTION, EXTENDED RELEASE / PERIARTICULAR | RLD | 2021-05-12 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N211988-004 | ZYNRELEF KIT | 400MG/14ML (29.25MG/ML);12MG/14ML (0.88MG/ML) | SOLUTION, EXTENDED RELEASE / PERIARTICULAR | RLD, RS | 2021-05-12 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N211988-001 | ZYNRELEF KIT | 60MG/2.3ML (29.25MG/ML);1.8MG/2.3ML (0.88MG/ML) | SOLUTION, EXTENDED RELEASE / PERIARTICULAR | RLD | 2021-05-12 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N211988-002 | ZYNRELEF KIT | 200MG/7ML (29.25MG/ML);6MG/7ML (0.88MG/ML) | SOLUTION, EXTENDED RELEASE / PERIARTICULAR | RLD, RS | 2021-05-12 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N211988-003 | ZYNRELEF KIT | 300MG/10.5ML (29.25MG/ML);9MG/10.5ML (0.88MG/ML) | SOLUTION, EXTENDED RELEASE / PERIARTICULAR | RLD | 2021-05-12 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N211988-004 | ZYNRELEF KIT | 400MG/14ML (29.25MG/ML);12MG/14ML (0.88MG/ML) | SOLUTION, EXTENDED RELEASE / PERIARTICULAR | RLD, RS | 2021-05-12 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N211988-001 | ZYNRELEF KIT | 60MG/2.3ML (29.25MG/ML);1.8MG/2.3ML (0.88MG/ML) | SOLUTION, EXTENDED RELEASE / PERIARTICULAR | RLD | 2021-05-12 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N211988-002 | ZYNRELEF KIT | 200MG/7ML (29.25MG/ML);6MG/7ML (0.88MG/ML) | SOLUTION, EXTENDED RELEASE / PERIARTICULAR | RLD, RS | 2021-05-12 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N211988-003 | ZYNRELEF KIT | 300MG/10.5ML (29.25MG/ML);9MG/10.5ML (0.88MG/ML) | SOLUTION, EXTENDED RELEASE / PERIARTICULAR | RLD | 2021-05-12 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N211988-004 | ZYNRELEF KIT | 400MG/14ML (29.25MG/ML);12MG/14ML (0.88MG/ML) | SOLUTION, EXTENDED RELEASE / PERIARTICULAR | RLD, RS | 2021-05-12 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N211988-001 | ZYNRELEF KIT | 60MG/2.3ML (29.25MG/ML);1.8MG/2.3ML (0.88MG/ML) | SOLUTION, EXTENDED RELEASE / PERIARTICULAR | RLD | 2021-05-12 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N211988-002 | ZYNRELEF KIT | 200MG/7ML (29.25MG/ML);6MG/7ML (0.88MG/ML) | SOLUTION, EXTENDED RELEASE / PERIARTICULAR | RLD, RS | 2021-05-12 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N211988-003 | ZYNRELEF KIT | 300MG/10.5ML (29.25MG/ML);9MG/10.5ML (0.88MG/ML) | SOLUTION, EXTENDED RELEASE / PERIARTICULAR | RLD | 2021-05-12 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N211988-004 | ZYNRELEF KIT | 400MG/14ML (29.25MG/ML);12MG/14ML (0.88MG/ML) | SOLUTION, EXTENDED RELEASE / PERIARTICULAR | RLD, RS | 2021-05-12 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N211988-001 | ZYNRELEF KIT | 60MG/2.3ML (29.25MG/ML);1.8MG/2.3ML (0.88MG/ML) | SOLUTION, EXTENDED RELEASE / PERIARTICULAR | RLD | 2021-05-12 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N211988-002 | ZYNRELEF KIT | 200MG/7ML (29.25MG/ML);6MG/7ML (0.88MG/ML) | SOLUTION, EXTENDED RELEASE / PERIARTICULAR | RLD, RS | 2021-05-12 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N211988-003 | ZYNRELEF KIT | 300MG/10.5ML (29.25MG/ML);9MG/10.5ML (0.88MG/ML) | SOLUTION, EXTENDED RELEASE / PERIARTICULAR | RLD | 2021-05-12 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N211988-004 | ZYNRELEF KIT | 400MG/14ML (29.25MG/ML);12MG/14ML (0.88MG/ML) | SOLUTION, EXTENDED RELEASE / PERIARTICULAR | RLD, RS | 2021-05-12 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N211988-001 | ZYNRELEF KIT | 60MG/2.3ML (29.25MG/ML);1.8MG/2.3ML (0.88MG/ML) | SOLUTION, EXTENDED RELEASE / PERIARTICULAR | RLD | 2021-05-12 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N211988-002 | ZYNRELEF KIT | 200MG/7ML (29.25MG/ML);6MG/7ML (0.88MG/ML) | SOLUTION, EXTENDED RELEASE / PERIARTICULAR | RLD, RS | 2021-05-12 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N211988-003 | ZYNRELEF KIT | 300MG/10.5ML (29.25MG/ML);9MG/10.5ML (0.88MG/ML) | SOLUTION, EXTENDED RELEASE / PERIARTICULAR | RLD | 2021-05-12 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N211988-004 | ZYNRELEF KIT | 400MG/14ML (29.25MG/ML);12MG/14ML (0.88MG/ML) | SOLUTION, EXTENDED RELEASE / PERIARTICULAR | RLD, RS | 2021-05-12 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N211988-001 | ZYNRELEF KIT | 60MG/2.3ML (29.25MG/ML);1.8MG/2.3ML (0.88MG/ML) | SOLUTION, EXTENDED RELEASE / PERIARTICULAR | RLD | 2021-05-12 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N211988-002 | ZYNRELEF KIT | 200MG/7ML (29.25MG/ML);6MG/7ML (0.88MG/ML) | SOLUTION, EXTENDED RELEASE / PERIARTICULAR | RLD, RS | 2021-05-12 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N211988-003 | ZYNRELEF KIT | 300MG/10.5ML (29.25MG/ML);9MG/10.5ML (0.88MG/ML) | SOLUTION, EXTENDED RELEASE / PERIARTICULAR | RLD | 2021-05-12 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N211988-004 | ZYNRELEF KIT | 400MG/14ML (29.25MG/ML);12MG/14ML (0.88MG/ML) | SOLUTION, EXTENDED RELEASE / PERIARTICULAR | RLD, RS | 2021-05-12 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N211988-001 | ZYNRELEF KIT | 60MG/2.3ML (29.25MG/ML);1.8MG/2.3ML (0.88MG/ML) | SOLUTION, EXTENDED RELEASE / PERIARTICULAR | RLD | 2021-05-12 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N211988-002 | ZYNRELEF KIT | 200MG/7ML (29.25MG/ML);6MG/7ML (0.88MG/ML) | SOLUTION, EXTENDED RELEASE / PERIARTICULAR | RLD, RS | 2021-05-12 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N211988-003 | ZYNRELEF KIT | 300MG/10.5ML (29.25MG/ML);9MG/10.5ML (0.88MG/ML) | SOLUTION, EXTENDED RELEASE / PERIARTICULAR | RLD | 2021-05-12 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N211988-004 | ZYNRELEF KIT | 400MG/14ML (29.25MG/ML);12MG/14ML (0.88MG/ML) | SOLUTION, EXTENDED RELEASE / PERIARTICULAR | RLD, RS | 2021-05-12 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N211988-001 | ZYNRELEF KIT | 60MG/2.3ML (29.25MG/ML);1.8MG/2.3ML (0.88MG/ML) | SOLUTION, EXTENDED RELEASE / PERIARTICULAR | RLD | 2021-05-12 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N211988-002 | ZYNRELEF KIT | 200MG/7ML (29.25MG/ML);6MG/7ML (0.88MG/ML) | SOLUTION, EXTENDED RELEASE / PERIARTICULAR | RLD, RS | 2021-05-12 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N211988-003 | ZYNRELEF KIT | 300MG/10.5ML (29.25MG/ML);9MG/10.5ML (0.88MG/ML) | SOLUTION, EXTENDED RELEASE / PERIARTICULAR | RLD | 2021-05-12 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N211988-004 | ZYNRELEF KIT | 400MG/14ML (29.25MG/ML);12MG/14ML (0.88MG/ML) | SOLUTION, EXTENDED RELEASE / PERIARTICULAR | RLD, RS | 2021-05-12 | d8e5a09893c0… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | N211988-001 | 10398686 | 2034-03-13 | Drug product | 2021-05-26 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N211988-001 | 11253504 | 2034-03-13 | U-3118 | 2022-03-02 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N211988-001 | 9592227 | 2034-03-13 | U-3118 | Drug product | 2021-05-26 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N211988-001 | 9744163 | 2034-03-13 | Drug product | 2021-05-26 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N211988-001 | 9913909 | 2034-03-13 | U-3118 | 2021-05-26 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N211988-001 | 10098957 | 2035-04-20 | U-3118 | 2021-05-26 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N211988-001 | 10213510 | 2035-04-20 | U-3118 | Drug product | 2021-05-26 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N211988-001 | 10632199 | 2035-04-20 | U-3118 | Drug product | 2021-05-26 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N211988-001 | 10898575 | 2035-04-20 | U-3118 | Drug product | 2021-05-26 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N211988-001 | 10980886 | 2035-04-20 | Drug product | 2021-05-26 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N211988-001 | 11083730 | 2035-04-20 | U-3118 | Drug product | 2021-08-25 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N211988-001 | 11083797 | 2035-04-20 | U-3118 | Drug product | 2021-08-25 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N211988-001 | 11413350 | 2035-04-20 | U-3417 | 2022-09-15 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N211988-001 | 9694079 | 2035-04-20 | U-3118 | Drug product | 2021-05-26 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N211988-001 | 9801945 | 2035-04-20 | U-3118 | Drug product | 2021-05-26 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N211988-001 | 11844837 | 2036-04-21 | U-3417 | 2024-01-03 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N211988-002 | 10398686 | 2034-03-13 | Drug product | 2021-05-26 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N211988-002 | 11253504 | 2034-03-13 | U-3118 | 2022-03-02 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N211988-002 | 9592227 | 2034-03-13 | U-3118 | Drug product | 2021-05-26 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N211988-002 | 9744163 | 2034-03-13 | Drug product | 2021-05-26 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N211988-002 | 9913909 | 2034-03-13 | U-3118 | 2021-05-26 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N211988-002 | 10098957 | 2035-04-20 | U-3118 | 2021-05-26 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N211988-002 | 10213510 | 2035-04-20 | U-3118 | Drug product | 2021-05-26 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N211988-002 | 10632199 | 2035-04-20 | U-3118 | Drug product | 2021-05-26 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N211988-002 | 10898575 | 2035-04-20 | U-3118 | Drug product | 2021-05-26 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N211988-002 | 10980886 | 2035-04-20 | Drug product | 2021-05-26 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N211988-002 | 11083730 | 2035-04-20 | U-3118 | Drug product | 2021-08-25 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N211988-002 | 11083797 | 2035-04-20 | U-3118 | Drug product | 2021-08-25 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N211988-002 | 11413350 | 2035-04-20 | U-3417 | 2022-09-15 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N211988-002 | 9694079 | 2035-04-20 | U-3118 | Drug product | 2021-05-26 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N211988-002 | 9801945 | 2035-04-20 | U-3118 | Drug product | 2021-05-26 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N211988-002 | 11844837 | 2036-04-21 | U-3417 | 2024-01-03 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N211988-003 | 10398686 | 2034-03-13 | Drug product | 2021-05-26 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N211988-003 | 11253504 | 2034-03-13 | U-3118 | 2022-03-02 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N211988-003 | 9592227 | 2034-03-13 | U-3118 | Drug product | 2021-05-26 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N211988-003 | 9744163 | 2034-03-13 | Drug product | 2021-05-26 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N211988-003 | 9913909 | 2034-03-13 | U-3118 | 2021-05-26 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N211988-003 | 10098957 | 2035-04-20 | U-3118 | 2021-05-26 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N211988-003 | 10213510 | 2035-04-20 | U-3118 | Drug product | 2021-05-26 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N211988-003 | 10632199 | 2035-04-20 | U-3118 | Drug product | 2021-05-26 | caaa826d4ba7… |
Observed Orange Book exclusivity history#
| Captured | Edition | Application-product | Exclusivity code | Expiration | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | N211988-001 | I-933 | 2027-01-23 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N211988-002 | I-933 | 2027-01-23 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N211988-003 | I-933 | 2027-01-23 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N211988-004 | I-933 | 2027-01-23 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | N211988-001 | I-933 | 2027-01-23 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N211988-002 | I-933 | 2027-01-23 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N211988-003 | I-933 | 2027-01-23 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N211988-004 | I-933 | 2027-01-23 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N211988-001 | I-933 | 2027-01-23 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N211988-002 | I-933 | 2027-01-23 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N211988-003 | I-933 | 2027-01-23 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N211988-004 | I-933 | 2027-01-23 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N211988-001 | I-933 | 2027-01-23 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N211988-002 | I-933 | 2027-01-23 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N211988-003 | I-933 | 2027-01-23 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N211988-004 | I-933 | 2027-01-23 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N211988-001 | I-933 | 2027-01-23 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N211988-002 | I-933 | 2027-01-23 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N211988-003 | I-933 | 2027-01-23 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N211988-004 | I-933 | 2027-01-23 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N211988-001 | I-933 | 2027-01-23 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N211988-002 | I-933 | 2027-01-23 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N211988-003 | I-933 | 2027-01-23 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N211988-004 | I-933 | 2027-01-23 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N211988-001 | NP | 2024-05-12 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N211988-001 | I-933 | 2027-01-23 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N211988-002 | NP | 2024-05-12 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N211988-002 | I-933 | 2027-01-23 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N211988-003 | NP | 2024-05-12 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N211988-003 | I-933 | 2027-01-23 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N211988-004 | NP | 2024-05-12 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N211988-004 | I-933 | 2027-01-23 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N211988-001 | NP | 2024-05-12 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N211988-001 | I-933 | 2027-01-23 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N211988-002 | NP | 2024-05-12 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N211988-002 | I-933 | 2027-01-23 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N211988-003 | NP | 2024-05-12 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N211988-003 | I-933 | 2027-01-23 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N211988-004 | NP | 2024-05-12 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N211988-004 | I-933 | 2027-01-23 | 2680178bc6a6… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ZYNRELEF | BUPIVACAINE AND MELOXICAM | Heron Therapeutics, Inc. | dab484a7-9353-43ba-9e74-7fab910c712b | 2026-04-20 | Boxed warning, Warnings, Adverse reactions | 211988 NDA211988 47426-301 47426-303 47426-304 47426-302 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 47426-301 | ZYNRELEF | BUPIVACAINE and MELOXICAM | Heron Therapeutics, Inc. | NDA | Current |
| 47426-301 | ZYNRELEF | BUPIVACAINE and MELOXICAM | Heron Therapeutics, Inc. | NDA | Current |
| 47426-301 | ZYNRELEF | BUPIVACAINE and MELOXICAM | Heron Therapeutics, Inc. | NDA | Current |
| 47426-302 | ZYNRELEF | BUPIVACAINE and MELOXICAM | Heron Therapeutics, Inc. | NDA | Current |
| 47426-302 | ZYNRELEF | BUPIVACAINE and MELOXICAM | Heron Therapeutics, Inc. | NDA | Current |
| 47426-302 | ZYNRELEF | BUPIVACAINE and MELOXICAM | Heron Therapeutics, Inc. | NDA | Current |
| 47426-303 | ZYNRELEF | BUPIVACAINE and MELOXICAM | Heron Therapeutics, Inc. | NDA | Current |
| 47426-303 | ZYNRELEF | BUPIVACAINE and MELOXICAM | Heron Therapeutics, Inc. | NDA | Current |
| 47426-303 | ZYNRELEF | BUPIVACAINE and MELOXICAM | Heron Therapeutics, Inc. | NDA | Current |
| 47426-304 | ZYNRELEF | BUPIVACAINE and MELOXICAM | Heron Therapeutics, Inc. | NDA | Current |
| 47426-304 | ZYNRELEF | BUPIVACAINE and MELOXICAM | Heron Therapeutics, Inc. | NDA | Current |
| 47426-304 | ZYNRELEF | BUPIVACAINE and MELOXICAM | Heron Therapeutics, Inc. | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 85651 | SUPPL | 2026-04-07 |
| 85650 | SUPPL | 2026-04-07 |
| 80401 | SUPPL | 2024-11-25 |
| 80318 | SUPPL | 2024-11-22 |
| 77885 | SUPPL | 2024-03-21 |
| 77297 | SUPPL | 2024-01-25 |
| 77284 | SUPPL | 2024-01-24 |
| 71469 | SUPPL | 2022-06-28 |
| 70687 | ORIG | 2022-04-05 |
| 69526 | SUPPL | 2021-12-10 |
| 69520 | SUPPL | 2021-12-09 |
| 67484 | ORIG | 2021-05-13 |
| 67481 | ORIG | 2021-05-13 |